Sir,

*Trueperella bernardiae* is a facultative anaerobic gram-positive coccobacillus which is part of the normal microbiota of human skin and the oropharynx. This microorganism has been reported in only few cases of human infection, especially in wound and prosthetic joint infections \[[@cit0001]-[@cit0003]\]. On the other hand, *Actinotignum sanguinis* is a small facultative anaerobic gram-positive rod which forms part of the normal urogenital flora. They grow slowly and especially under anaerobic or in atmosphere enriched with CO~2~. *Actinotignum* species have been rarely associated with urinary tract infections \[[@cit0004]\] and bacteremia \[[@cit0005]\].

We report a rare case of breast abscess caused by these two pathogens. To our best knowledge, this is the first report of breast abscess caused by these two microorganisms together. [Table 1](#t0001){ref-type="table"} shows all published cases of *T. bernardiae* and/or *A. sanguinis* infections.

###### 

Cases with infection caused by Trueperella bernardiae and/or Actinotignum sanguinis.

  Patient (year of publication) Author   Age (years)/sex   Microorganism                  Localization of infection   Microbiological diagnosis
  -------------------------------------- ----------------- ------------------------------ --------------------------- -------------------------------------------------------------------------
  1 (1996) Ieven M                       69/M              *Actinomyces bernardiae*       Urinary tract               Urine, perirenal abscess and necrotic tissue cultures Blood culture (+)
  2 (1998) Adderson EE                   19/F              *Arcanobacterium bernardiae*   Hip                         Synovial fluid culture
  3 (1998) Lepargneur JP                 75/M              *Arcanobacterium bernardiae*   Urinary tract               Urine culture
  4 (2009) Bemer P                       63/M              *Arcanobacterium bernardiae*   Knee                        Intraoperatory specimen
                                                           *Staphylococcus. aureus*                                   
  5 (2009) Loïez C                       78/M              *Arcanobacterium bernardiae*   Hip prosthesis              Intraoperatory specimen
  6 (2010) Sirijatuphat R                60/M              *Arcanobacterium bernardiae*   Kidney                      Perinephric drainage culture
                                                                                          Pleura                      
  7 (2010) Clarke TM                     62/F              *Arcanobacterium bernardiae*   Skin abscess                Abscess and tissue cultures
                                                           *Morganella morganii*                                      
  8 (2011) Weitzel T                     72/F              *Arcanobacterium bernardiae*   Blood                       Blood cultures (+)
  9 (2013) Otto MP                       78/F              *Trueperella bernardiae*       Wound                       Ulcer culture
                                                           *Bacteroides fragilis*                                     Blood cultures (+)
                                                           *Enterococcus avium*                                       
  10 (2015) Parha E                      68/F              *Trueperella bernardiae*       Brain                       Abscess culture
                                                           *Peptoniphilus harei*                                      
  11 (2015) Schneider UV                 45/M              *Trueperella bernardiae*       Skin ulcers                 Ulcer tissue culture
                                                           *Peptoniphilus lacrimalis*                                 
  12 (2016) Rattes ALR                   24/F              *Trueperella bernardiae*       Wound                       Umbilical secretion culture
  13 (2016) Gilarranz R                  73/F              *Trueperella bernardiae*       Knee prosthesis             Synovial fluid
                                                                                                                      Blood cultures (+)
  14 (2016) VanGorder B                  77/F              *Trueperella bernardiae*       Skin                        Drainage abscess culture
  15 (2017) Cobo F                       69/F              *Trueperella bernardiae*       Wound                       Wound secretion culture
  16 (2017) Cobo F                       70/F              *Trueperella bernardiae*       Inguinal granuloma          Wound secretion culture
                                                           *Escherichia coli*                                         
  17 (2017) Pedersen H.                  NR                *Actinotignum sanguinis*       Blood                       Blood cultures (+)
  18 (PR/2018) Calatrava E               39/F              *Trueperella bernardiae*       Breast abscess              Drainage abscess culture
                                                           *Actinotignum sanguinis*                                   

M: male; F: female; NR: not reported; PR: present report

A 39-year-old woman refers ten days history of pain and local swelling in her right breast. Her clinical history was unremarkable, and she was in treatment with cloxacillin (1g /8h) for seven days. The abscess was drained by puncture and the fluid obtained sent to the microbiology laboratory for culture. The sample was inoculated in blood agar (both aerobic and anaerobic) (BD Columbia Agar 5% Sheepblood^®^, Becton Dickinson) chocolate agar (BD Choco Agar, Becton Dickinson), thioglycolate broth (BD™ Fluid Thioglycolate Medium, Becton Dickinson), Mannitol agar (BD Mannitol Salt, Becton Dickinson) and MacConkey (BD Mac Conkey II, Becton Dickinson).

Gram stain of the abscess showed gram positive bacilli, and on the second day of incubation two types of colonies grew on both aerobic and anaerobic blood agar and chocolate agar. They were identified with MALDI-TOF MS (Bruker Biotyper, Billerica, MA, USA) as *Trueperella bernardiae* (score 2,13) and *Actinotignum sanguinis* (score 2,22). The MIC of different antibiotics was carried out by the E-test method in Brucella agar supplemented with hemin, vitamin K1 and lacked sheep blood incubated at 37°C. As no specific clinical breakpoints have been established for *T. bernardiae* and *A. sanguinis*, we used the EUCAST PK/PD (non-species related) clinical breakpoints. *T. bernardiae* was susceptible to ciprofloxacin (0.5 mg/L), gentamicin (1.5 mg/L), imipenem (0.016 mg/L), linezolid (0.25 mg/L), penicillin (0.032 mg/L), rifampicin (\<0.016 mg/L), tetracycline (0.094 mg/L), vancomycin (0.19 mg/L), and resistant to trimethoprim-sulfamethoxazole (\>32 mg/L), clindamycin (1 mg/L) and erythromycin (1 mg/L). *A. sanguinis* was susceptible to ciprofloxacin (0.5 mg/L), gentamicin (\<0.016 mg/L), linezolid (0.047 mg/L), penicillin (\<0.016 mg/L), vancomycin (\<0.016 mg/L), and resistant to trimethoprim/sulfamethoxazole (\>32 mg/L), clindamycin (\>256 mg/L) and erythromycin (\>256 mg/L). Antimicrobial treatment was changed to amoxicillin-clavulanic (875/125 mg/8h) for 10 days, and at three months of follow-up the woman was asymptomatic.

The diagnosis of *T. bernardiae* and *A. sanguinis* is based on culture of an adequate sample. Identification using conventional laboratory methods could be difficult and when isolated in clinical samples these microorganisms are usually not identified, especially *T. bernardiae* due to it coryneform aspect. The recent introduction of mass spectrometry for routine analysis in the clinical laboratories may help in the final identification of these pathogens, and can help to know the true incidence of infections with these bacteria. For this reason it is highly recommended to use the MALDI-TOF method for identification.

Overall, drug resistance in *T. bernardiae* and *A. sanguinis* may be not considered still a problem. According to different studies, *T. bernardiae* was susceptible to all antimicrobials tested, except to ciprofloxacin \[[@cit0006], [@cit0007]\]. On the other hand, the genus *Actinotignum* has demonstrated high susceptibility to ß-lactams and vancomycin \[[@cit0005]\]. In other study, 12 isolates of *Actinotignum* spp. were susceptible to penicillin \[[@cit0008]\]. However, treatment of choice for these microorganisms has not been clearly established due to the scarcity of data and the absence of breakpoints for these bacteria. Further studies are necessary in order to establish the best therapeutic option.

In summary, it is still unknown the true clinical implications of *T. bernardiae* and *A. sanguinis*, but with the generalized use of MALDI-TOF in the majority of laboratories, the diagnosis of these pathogens implicated in human infections probably will increase. Microbiologists should be aware of these microorganisms especially if the new diagnostic techniques area applied.
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